WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 16'3601 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 20'8891 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 3'432  3'420  3'408  3'397  3'386  3'321  3'110  2'916 
Births 49  49  49  49  49  54  57  56 
Surviving infants 48  48  48  49  49  53  56  54 
Pop. less than 5 years 241  242  243  245  246  271  271  277 
Pop. less than 15 years 735  739  744  749  754  816  809  785 
Female 15-49 years 823  822  820  819  817  806  743  696 

Number of reported cases

(Click for retrospective incidence data for Uruguay)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  110  141 
Mumps
ChartChart
  2'087  205  113  132  20 
Pertussis
ChartChart
  777  323  598  639  161  192 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  15 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uruguay)
Vaccine year result method % card seen                                                
BCG          98  99  98  99  99  99  99  56 
DTP1          99  99  98  98  99  92 
DTP3          95  95  95  95  95  90  97  53 
DTP4         
IPV1          99  99 
HepB_BD         
HepB3          95  95  95  95  95  92 
Hib3          95  95  95  95  95  88 
JapEnc         
MCV1          96  96  96  96  95  89  97  50 
MCV2          93  93  92 
PCV1          99  99  96  97  99 
PCV3          94  95  93  93  92 
Pol3          95  95  95  95  95  92  97  59 
Rota1         
RotaC         
Rubella1          95  96  96  96  95 
TT2plus          18 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uruguay)
BCG
ChartChart
  98  99  98  99  99  99  99  56 
DTP1
ChartChart
  99  99  98  98  99  92  98  77 
DTP3
ChartChart
  95  95  94  95  95  90  97  53 
HepB3
ChartChart
  95  95  94  95  95  92 
HepB_BD
ChartChart
 
Hib3
ChartChart
  95  95  94  95  95  88 
MCV1
ChartChart
  96  96  96  96  95  89  97  50 
MCV2
ChartChart
  93  93  92 
PCV3
ChartChart
  94  95  93  93  92 
Pol3
ChartChart
  95  95  94  95  95  92  97  59 
RCV1
ChartChart
  96  96  96  96  95  89  97 
RotaC
ChartChart
 

Number of districts in the country 278  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 15 months; Yes contra-indication to pertussis
DTwP 5 years; Yes
DTwPHibHepB 2, 4, 6, 15 months; Yes
HIB 2, 4, 6, 15 months; Yes contra- indication to pertussis
HPV 12 years (x3);
HepA 15, 21 months; Yes
HepB_Adult HCW and special risk groups
HepB_Pediatric 2, 4, 6, 15 months; Yes Contra-indication to pertussis
IPV 2, 4, 6, 15 months; Yes
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6 months to 5 years; Yes and children in risk groups
MMR 1, 5 years; Yes
Pneumo_conj 2, 4 months; 1 year; Yes
Pneumo_ps > =65 years; Yes and risk groups
Td 22 years; Yes every 10 years
Tdap 12 years; Yes pregnant women and health care workers
Varicella 1, 5 years; Yes
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2020  2015-2020  2010-2015  2010-2015  2010-2015  2010-2015  2009-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 278  278        275   

System performance

Total Nº districts in country number 278  275  275  275  275  275  275 
Nº districts with DTP3 coverage >=80% number 278  278  278  275  275  275  275 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  101  101  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 253  249  268  264  253  250  256 
% of districts with MCV1 coverage >=95% From 0 to 100% 91  91  97  96  92  91  93 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes    Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100    100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.